I
BMY icon

IberiaBank’s Bristol-Myers Squibb BMY Stock Holding History

IberiaBank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.57M Buy
60,752
+3,567
+6% +$213K 0.42% 77
2020
Q1 		$3.19M Sell
57,185
-2,497
-4% -$153K 0.42% 75
2019
Q4 		$3.83M Buy
59,682
+11,393
+24% +$652K 0.4% 76
2019
Q3 		$2.45M Sell
48,289
-3,450
-7% -$162K 0.28% 89
2019
Q2 		$2.35M Buy
51,739
+2,005
+4% +$93.4K 0.26% 92
2019
Q1 		$2.37M Buy
49,734
+24,503
+97% +$1.22M 0.28% 87
2018
Q4 		$1.31M Sell
25,231
-2,106
-8% -$113K 0.17% 118
2018
Q3 		$1.7M Buy
27,337
+4,383
+19% +$260K 0.21% 116
2018
Q2 		$1.27M Sell
22,954
-1,105
-5% -$59.7K 0.22% 120
2018
Q1 		$1.52M Buy
24,059
+373
+2% +$24K 0.3% 108
2017
Q4 		$1.45M Buy
23,686
+6,934
+41% +$434K 0.23% 119
2017
Q3 		$1.08M Buy
16,752
+11,405
+213% +$666K 0.18% 132
2017
Q2 		$298K Sell
5,347
-676
-11% -$36.8K 0.09% 140
2017
Q1 		$328K Buy
6,023
+207
+4% +$11.4K 0.1% 137
2016
Q4 		$340K Sell
5,816
-1,296
-18% -$70.9K 0.12% 123
2016
Q3 		$383K Sell
7,112
-1,732
-20% -$111K 0.16% 101
2016
Q2 		$650K Sell
8,844
-40,801
-82% -$2.88M 0.29% 74
2016
Q1 		$3.17M Sell
49,645
-49
-0.1% -$3.09K 1.5% 29
2015
Q4 		$3.42M Buy
49,694
+3,060
+7% +$202K 1.54% 30
2015
Q3 		$2.76M Buy
46,634
+9,904
+27% +$628K 1.42% 30
2015
Q2 		$2.44M Buy
36,730
+733
+2% +$48.3K 1.09% 38
2015
Q1 		$2.32M Buy
35,997
+3,056
+9% +$191K 1.04% 39
2014
Q4 		$1.95M Sell
32,941
-2,954
-8% -$167K 1.06% 36
2014
Q3 		$1.84M Buy
35,895
+226
+0.6% +$11.3K 1.03% 40
2014
Q2 		$1.73M Buy
35,669
+204
+0.6% +$10.1K 0.97% 44
2014
Q1 		$1.84M Sell
35,465
-1,146
-3% -$61K 1.14% 33
2013
Q4 		$1.95M Sell
36,611
-21,655
-37% -$1.1M 1.27% 31
2013
Q3 		$2.7M Buy
58,266
+3,874
+7% +$170K 1.77% 9
2013
Q2 		$2.43M Buy
+54,392
New +$2.36M 1.84% 7

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

IberiaBank's BMY Position: Q2 2020 in Review

IberiaBank increased its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2020, buying an estimated $213K and bringing the position to 60,752 shares worth $3.57M. The position accounts for 0.42% of the portfolio, ranked #77.

IberiaBank first reported a position in BMY in Q2 2013 and has held it in 29 quarters since. The position peaked at $3.83M in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • IberiaBank held 60,752 shares of Bristol-Myers Squibb worth $3.57M as of Q2 2020.
  • IberiaBank bought 3,567 Bristol-Myers Squibb shares in Q2 2020, an estimated $213K.
  • Bristol-Myers Squibb made up 0.42% of IberiaBank's portfolio in Q2 2020, its #77 holding.
  • IberiaBank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 29 quarters since.
  • IberiaBank's Bristol-Myers Squibb position peaked at $3.83M in Q4 2019.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.